ESC 365 - Effect of trimetazidine on clinical events after primary percutaneos coronary intervention in patients with ST-elevation myocardial infarction

ESC Premium Access

Effect of trimetazidine on clinical events after primary percutaneos coronary intervention in patients with ST-elevation myocardial infarction

Session: Poster Session 6 - Coronary artery disease: diagnosis, pharmacotherapy and revascularisation

Topic: Revascularisation

Speaker: Professor H. Hayrapetyan (Yerevan, AM)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Hamlet Hayrapetyan

Erebouni Medical Center, Yerevan (Armenia)

0 follower

19 more presentations in this session

Practice-level variation in use of optimal medical treatment during hospitalization: a multi-level methodological approach

Speaker: Professor J. Lee (Daegu, KR)

Moderate versus high-intensity statin therapy in east asian patients with angina undergoing PCI with DES: a propensity-score matching analysis

Speaker: Doctor M. Park (Daejeon, KR)

Effectiveness and tolerability of trimetazidine 80 mg od for the treatment of stable angina pectoris in 3066 patients in routine clinical practice: results from ODA trial

Speaker: Professor M. Glezer (Moscow, RU)

Impact of serum fibrinogen on 2-year mortality following percutaneous coronary intervention--a large cohort study from china

Speaker: Doctor P. Jiang (Beijing, CN)

Predictors of No-reflow in Primary PCI patients with novel insight on thrombus aspiration.

Speaker: Doctor A. Khairy (Assiut, EG)

Access the full session

Poster Session 6 - Coronary artery disease: diagnosis, pharmacotherapy and revascularisation

Speakers: Professor H. Hayrapetyan, Professor J. Lee, Doctor M. Park, Professor M. Glezer, Doctor P. Jiang...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources